Zinacef

— THERAPEUTIC DISORDERS TREATED —
  • Bacterial infections

Zinacef Generic Name & Formulations

General Description

Cefuroxime (as sodium) 750mg, 1.5g; IM or IV inj; sodium content 2.4mEq/g.

Pharmacological Class

Cephalosporin.

How Supplied

Vials—10

Manufacturer

Generic Availability

YES

Zinacef Indications

Indications

Susceptible bacterial septicemia, lower respiratory or urinary tract, skin and skin structure, meningitis, bone and joint infections, gonorrhea. Surgical prophylaxis.

Zinacef Dosage and Administration

Adult

Use IV route for serious infections. Usual duration of therapy: 5–10 days. Uncomplicated UTIs, skin and skin structure, disseminated gonorrhea, or uncomplicated pneumonia: 750mg every 8 hours. Severe or complicated infections, bone and joint: 1.5g every 8 hours; life-threatening: 1.5g every 6 hours; meningitis: max 3g every 8 hours. Uncomplicated gonorrhea: 1.5g IM once (divide into 2 injections) with 1g oral probenecid. Prophylaxis: see full labeling. Renal dysfunction: CrCl 10–20mL/min: 750mg every 12 hours; CrCl <10mL/min: 750mg every 24 hours. Coincide a dose for end of dialysis.

Children

<3 months: not established. Give in equally divided doses. ≥3 months: usual range: 50–100mg/kg per day every 6–8 hours. Bone and joint: 150mg/kg per day every 8 hours. Meningitis: 200–240mg/kg per day IV every 6–8 hours. Renal dysfunction: reduce dose.

Zinacef Contraindications

Not Applicable

Zinacef Boxed Warnings

Not Applicable

Zinacef Warnings/Precautions

Warnings/Precautions

Penicillin allergy. Renal impairment, reduce dose. Monitor prothrombin time (in patients at risk), renal function. GI disease (esp. colitis). Elderly. Pregnancy (Cat.B). Nursing mothers.

Zinacef Pharmacokinetics

See Literature

Zinacef Interactions

Interactions

Avoid aminoglycosides, furosemide, ethacrynic acid, other nephrotoxic drugs. May cause false (+) glucose test with Clinitest, Benedict's or Fehling's soln. Potentiated by probenecid.

Zinacef Adverse Reactions

Adverse Reactions

Local reactions, blood dyscrasias, elevated liver enzymes; rarely: GI upset, rash (may be serious, eg, Stevens-Johnson syndrome), drug fever, anaphylaxis, interstitial nephritis, seizures, hearing loss in children treated for meningitis.

Zinacef Clinical Trials

See Literature

Zinacef Note

Not Applicable

Zinacef Patient Counseling

See Literature